VR Logo

Rocket Pharmaceuticals Inc. (RCKT) download report


Healthcare | Biotechnology & Pharma Research

Rocket Pharmaceuticals Inc. (RCKT) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases.

IPO Date: 18-Feb-2015

CEO & Director: Dr. Gaurav D. Shah M.D.

Pres & COO: Ms. Kinnari Patel M.B.A., MBA, Pharm.D., PharmD

Listing: NASDAQ: RCKT

Country: United States

Headquarters: Cranbury, NJ

Website: https://rocketpharma.com

Key Facts

Market cap: $790.05 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-171.87 Mln

Cash: $346.59 Mln

Total Debt: $22.43 Mln

Insider's Holding: 4.40%

Liquidity: Low

52 Week range: $7.58 - 49.66

Shares outstanding: 65,837,900

10 Years Aggregate:

  • CFO: $-418.18 Mln
  • EBITDA: $-546.31 Mln
  • Net Profit: $-624.10 Mln

Stock Performance

Time Period Rocket Pharmaceuticals (RCKT) S&P BSE Sensex S&P Small-Cap 600
YTD-36.10-9.49-17.79
1 month28.69-2.87-2.72
3 months-9.88-8.59-12.17
1 Year-67.550.81-15.82
3 Years-6.2710.397.14
5 Years14.1411.116.20
10 Years--12.0010.33
As on 24-Jun-2022
Year Rocket Pharmaceuticals (RCKT) S&P Small-Cap 600 S&P BSE Sensex
2021-60.1925.2721.99
2020140.959.5715.75
201953.5820.8614.38
201841.68-9.705.87
2017-57.2111.7327.91
2016-46.1624.741.95